Cargando…

Walking delay as leading symptom in late-onset Pompe disease

Detalles Bibliográficos
Autores principales:	Gökce, S, Karabul, N, Herzog, A, Mengel, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667070/ http://dx.doi.org/10.1186/1471-2474-14-S2-P22

Ejemplares similares

Cytokines in treated and untreated Pompe patients
por: Karabul, N, et al.
Publicado: (2013)

The Pompe Registry: tracking Pompe disease symptoms in a broad patient population
por: Byrne, B, et al.
Publicado: (2008)

Extent, impact, and predictors of diagnostic delay in Pompe disease: A combined survey approach to unveil the diagnostic odyssey
por: Lagler, Florian B., et al.
Publicado: (2019)

Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
por: Schoser, Benedikt
Publicado: (2013)

PReS-FINAL-2244: Ultrasound examination reveals typical alterations in joints of mucopolysaccharidosis (MPS) patients
por: Karabul, N, et al.
Publicado: (2013)

Hypothyroidism in late-onset Pompe disease
por: Schneider, Joseph, et al.
Publicado: (2016)

Pompe disease: the role of MRI
por: Fernández, C Pérez, et al.
Publicado: (2013)

Late-Onset Pompe Disease with Nemaline Bodies
por: Frezza, E., et al.
Publicado: (2018)

A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations
por: Herzog, Andreas, et al.
Publicado: (2012)

Pain in adult patients with Pompe disease
por: Karabul, N., et al.
Publicado: (2014)

Late-onset Pompe disease manifests in the brain
por: Finsterer, Josef
Publicado: (2019)

Pregnancy Outcomes in Late Onset Pompe Disease
por: Goker-Alpan, Ozlem, et al.
Publicado: (2020)

Pompe disease- experience from South India
por: Lingappa, Lokesh, et al.
Publicado: (2013)

Spectrum of Pompe disease in childhood – The Toronto experience
por: Raiman, J, et al.
Publicado: (2013)

Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy
por: Lollert, André, et al.
Publicado: (2018)

Is the brain involved in patients with late‐onset Pompe disease?
por: van den Dorpel, Jan J. A., et al.
Publicado: (2022)

Enzyme replacement therapy and fatigue in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

Description of the first two cases of Pompe disease in Bulgaria
por: Tournev, I, et al.
Publicado: (2013)

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
por: Byrne, Barry J., et al.
Publicado: (2017)

Development of a disease severity scoring system for patients with Pompe disease
por: Giannini, E, et al.
Publicado: (2008)

Fatigue: an important feature of late-onset Pompe disease
por: Hagemans, M. L. C., et al.
Publicado: (2007)

Bone density in patients with late onset Pompe disease
por: Papadimas, George, et al.
Publicado: (2012)

Response: Late-onset Pompe disease manifests in the brain
por: Schneider, Ilka, et al.
Publicado: (2019)

Treatment Dilemma in Children with Late-Onset Pompe Disease
por: Faraguna, Martha Caterina, et al.
Publicado: (2023)

A Comprehensive Update on Late-Onset Pompe Disease
por: Labella, Beatrice, et al.
Publicado: (2023)

Impact of enzyme replacement therapy on survival in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus
por: Fatehi, Farzad, et al.
Publicado: (2021)

Highlighting intrafamilial clinical heterogeneity in late-onset Pompe disease()
por: Papadopoulos, C., et al.
Publicado: (2013)

Pompe practice survey of Canadian (Ontario) rheumatologists
por: Thorne, Carter, et al.
Publicado: (2013)

Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
por: Dimachkie, Mazen M., et al.
Publicado: (2022)

A genetic modifier of symptom onset in Pompe disease
por: Bergsma, Atze J., et al.
Publicado: (2019)

S1.5 Role of the pulmonologist in the late-onset Pompe disease
por: Fiorentino, Giuseppe, et al.
Publicado: (2011)

Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014)

Analysis of voice quality in patients with late-onset Pompe disease
por: Szklanny, Krzysztof, et al.
Publicado: (2016)

Bright tongue sign in patients with late-onset Pompe disease
por: Karam, Chafic, et al.
Publicado: (2019)

Dynamic respiratory muscle function in late-onset Pompe disease
por: Smith, Barbara K., et al.
Publicado: (2019)

COVID‐19 infection in patients with late‐onset Pompe disease
por: Avelar, Jennifer, et al.
Publicado: (2022)

Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement
por: Al-Hashel, Jasem, et al.
Publicado: (2022)

Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment
por: Senarathne, Udara Dilrukshi, et al.
Publicado: (2022)

Effects of exercise training in 23 adults with Pompe disease receiving enzyme therapy
por: van den Berg, Linda, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g5282g9b3nrsb6r553meo1dttf